Business Description

Description
Biophytis SA is a France-based clinical-stage biotechnology company engaged in the development of drug candidates for the treatment of age-related and respiratory diseases. The company focuses on therapies that target degenerative processes associated with aging and improve functional outcomes. Its drug candidate, BIO101, is an orally administered small molecule under development for neuromuscular and respiratory indications, including sarcopenia, Duchenne muscular dystrophy (DMD), and respiratory failure.
Name Current Vs Industry Vs History
Cash-To-Debt
0.19
Equity-to-Asset
-1.18
Debt-to-Equity
-0.94
Debt-to-EBITDA
-1.12
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
74
3-Year EPS without NRI Growth Rate
72.7
3-Year FCF Growth Rate
72.7
Name Current Vs Industry Vs History
9-Day RSI
0.24
14-Day RSI
3.02
3-1 Month Momentum %
-44.44
6-1 Month Momentum %
24900
12-1 Month Momentum %
-81.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.35
Quick Ratio
0.35
Cash Ratio
0.13

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-178.1
Shareholder Yield %
-178.52
Name Current Vs Industry Vs History
ROA %
-108.39
ROIC %
-68.9
3-Year ROIIC %
-400.96
ROC (Joel Greenblatt) %
-2459.08
Moat Score
2

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-1.11
EV-to-EBITDA
-1.17
EV-to-Forward-Revenue
0.32
EV-to-FCF
-1.21
Earnings Yield (Greenblatt) %
-90.09
FCF Yield %
-348.47

Financials

BPTSY's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BPTSY

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Biophytis SA Executives

Details

GF Value™

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -6.545
Beta -3.1047
3-Year Sharpe Ratio 0.51
3-Year Sortino Ratio 15.05
Volatility % 4458.95
14-Day RSI 3.02
14-Day ATR ($) 0.000466
20-Day SMA ($) 0.25
12-1 Month Momentum % -81.88
52-Week Range ($) 0.001 - 2
Shares Outstanding (Mil) 11.98

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biophytis SA Filings

Filing Date Document Date Form
No Filing Data

Biophytis SA Stock Events

Financials Calendars
Event Date Price ($)
0.025:1 Stock Split 2024-04-23 9.82 (-12.32%)
0.1:1 Stock Split 2023-03-30 161.44 (-0.52%)
Show
Entries

Biophytis SA Frequently Asked Questions

What is Biophytis SA(BPTSY)'s stock price today?
The current price of BPTSY is $0.25. The 52 week high of BPTSY is $2.00 and 52 week low is $0.00.
When is next earnings date of Biophytis SA(BPTSY)?
The next earnings date of Biophytis SA(BPTSY) is .
Does Biophytis SA(BPTSY) pay dividends? If so, how much?
Biophytis SA(BPTSY) does not pay dividend.

Guru Commentaries on OTCPK:BPTSY

No articles.

Articles on Biophytis SA

No articles.

Headlines

See More
  • 1
No news.
  • 1